These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 12551742

  • 1. Effects of acute cholecystokinin infusion on hemispheric EEG asymmetry and coherence in healthy volunteers.
    Knott V, Mahoney C, Bradwejn J, Shlik J, Gunnarsson T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):179-84. PubMed ID: 12551742
    [Abstract] [Full Text] [Related]

  • 2. Acute cholecystokinin effects on event-related potentials in healthy volunteers.
    Knott VJ, Mahoney C, Gunnarsson T, Bradwejn J, Shlik J.
    Hum Psychopharmacol; 2002 Aug; 17(6):285-91. PubMed ID: 12404673
    [Abstract] [Full Text] [Related]

  • 3. Acute effects of cholecystokinin tetrapeptide on brain stem auditory evoked potentials in healthy volunteers.
    Gunnarsson T, Mahoney C, Shlik J, Bradwejn J, Knott V.
    Pharmacopsychiatry; 2003 Sep; 36(5):181-6. PubMed ID: 14571352
    [Abstract] [Full Text] [Related]

  • 4. Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients.
    Lopes FL, Oliveira MM, Freire RC, Caldirola D, Perna G, Bellodi L, Valença AM, Nascimento I, Piedade RA, Ribeiro P, Zin WA, Nardi AE.
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):357-63. PubMed ID: 19958206
    [Abstract] [Full Text] [Related]

  • 5. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E, Tõru I, Vasar V, Shlik J.
    J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
    [Abstract] [Full Text] [Related]

  • 6. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D, Torres S, Swain JE, Bradwejn J.
    Psychosom Med; 2005 Jun; 67(4):590-5. PubMed ID: 16046372
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O, Saletu B, Anderer P, Assandri A, di Padova C, Corrado M, Saletu-Zyhlarz GM.
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [Abstract] [Full Text] [Related]

  • 8. Dose ranging study of the effects of cholecystokinin in healthy volunteers.
    Bradwejn J, Koszycki D, Bourin M.
    J Psychiatry Neurosci; 1991 Jul; 16(2):91-5. PubMed ID: 1911739
    [Abstract] [Full Text] [Related]

  • 9. Effects of cortisol on the laterality of the neural correlates of episodic memory.
    Alhaj HA, Massey AE, McAllister-Williams RH.
    J Psychiatr Res; 2008 Oct; 42(12):971-81. PubMed ID: 18187154
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B, Anderer P, Wolzt M, Nosiska D, Assandri A, Noseda E, Nannipieri F, Saletu-Zyhlarz GM.
    Neuropsychobiology; 2009 Oct; 59(2):110-22. PubMed ID: 19365151
    [Abstract] [Full Text] [Related]

  • 11. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J, Koszycki D.
    Scand J Clin Lab Invest Suppl; 2001 Oct; 234():19-27. PubMed ID: 11713976
    [Abstract] [Full Text] [Related]

  • 12. Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men.
    Dépôt M, Merani S, Bradwejn J, Mukherjee J, Caillé J, Gutkowska J, Caillé G.
    J Psychiatry Neurosci; 1998 Nov; 23(5):298-304. PubMed ID: 9846035
    [Abstract] [Full Text] [Related]

  • 13. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E, Tõru I, Tasa G, Must A, Toover E, Lang A, Vasar V, Shlik J.
    Neurosci Lett; 2008 Dec 03; 446(2-3):88-92. PubMed ID: 18832011
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity to cholecystokinin-tetrapeptide in major depression.
    Koszycki D, Copen J, Bradwejn J.
    J Affect Disord; 2004 Jun 03; 80(2-3):285-90. PubMed ID: 15207943
    [Abstract] [Full Text] [Related]

  • 15. Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteers.
    Bradwejn J, LeGrand JM, Koszycki D, Bates JH, Bourin M.
    Am J Psychiatry; 1998 Feb 03; 155(2):280-2. PubMed ID: 9464212
    [Abstract] [Full Text] [Related]

  • 16. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Feb 03; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 17. Effect of aging on cholecystokinin-induced panic.
    Flint AJ, Koszycki D, Vaccarino FJ, Cadieux A, Boulenger JP, Bradwejn J.
    Am J Psychiatry; 1998 Feb 03; 155(2):283-5. PubMed ID: 9464213
    [Abstract] [Full Text] [Related]

  • 18. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
    Romański KW.
    J S Afr Vet Assoc; 2007 Dec 03; 78(4):209-14. PubMed ID: 18507220
    [Abstract] [Full Text] [Related]

  • 19. Effects of alcohol on spontaneous neuronal oscillations: a combined magnetoencephalography and electroencephalography study.
    Nikulin VV, Nikulina AV, Yamashita H, Rossi EM, Kähkönen S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 03; 29(5):687-93. PubMed ID: 15905011
    [Abstract] [Full Text] [Related]

  • 20. [Spectral analysis and EEG coherence in children with cerebral palsy: spastic diplegia].
    Kułak W, Sobaniec W.
    Przegl Lek; 2003 Jun 03; 60 Suppl 1():23-7. PubMed ID: 12945157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.